Drug profile · INN
belzutifan
WELIREG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
belzutifan (WELIREG) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN belzutifan
Brand WELIREG
Route ORAL
Formulation TABLET
ATC code L01XX74
Originator Merck KGaA, Darmstadt, Germany
Frequently asked questions
What is belzutifan?
belzutifan (WELIREG) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for belzutifan?
WELIREG is a marketed brand name for belzutifan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of belzutifan?
belzutifan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.